Unknown

Dataset Information

0

Integrated analysis of microRNA-target interactions with clinical outcomes for cancers.


ABSTRACT:

Background

Clinical statement alone is not enough to predict the progression of disease. Instead, the gene expression profiles have been widely used to forecast clinical outcomes. Many genes related to survival have been identified, and recently miRNA expression signatures predicting patient survival have been also investigated for several cancers. However, miRNAs and their target genes associated with clinical outcomes have remained largely unexplored.

Methods

Here, we demonstrate a survival analysis based on the regulatory relationships of miRNAs and their target genes. The patient survivals for the two major cancers, ovarian cancer and glioblastoma multiforme (GBM), are investigated through the integrated analysis of miRNA-mRNA interaction pairs.

Results

We found that there is a larger survival difference between two patient groups with an inversely correlated expression profile of miRNA and mRNA. It supports the idea that signatures of miRNAs and their targets related to cancer progression can be detected via this approach.

Conclusions

This integrated analysis can help to discover coordinated expression signatures of miRNAs and their target mRNAs that can be employed for therapeutics in human cancers.

SUBMITTER: Joung JG 

PROVIDER: S-EPMC4101396 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Integrated analysis of microRNA-target interactions with clinical outcomes for cancers.

Joung Je-Gun JG   Kim Dokyoon D   Lee Su Yeon SY   Kang Hwa Jung HJ   Kim Ju Han JH  

BMC medical genomics 20140508


<h4>Background</h4>Clinical statement alone is not enough to predict the progression of disease. Instead, the gene expression profiles have been widely used to forecast clinical outcomes. Many genes related to survival have been identified, and recently miRNA expression signatures predicting patient survival have been also investigated for several cancers. However, miRNAs and their target genes associated with clinical outcomes have remained largely unexplored.<h4>Methods</h4>Here, we demonstrat  ...[more]

Similar Datasets

| S-EPMC3677264 | biostudies-literature
| S-EPMC3982325 | biostudies-literature
| S-EPMC3753644 | biostudies-literature
| S-EPMC6304515 | biostudies-literature
| S-EPMC5722499 | biostudies-literature
| S-EPMC2703880 | biostudies-other
2013-01-22 | E-GEOD-39040 | biostudies-arrayexpress
| S-EPMC4150780 | biostudies-literature
| S-EPMC3378890 | biostudies-literature
2013-01-22 | GSE39040 | GEO